ORANGEBURG, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the first quarter of fiscal 2014, ended June 30, 2013, after the market closes on Monday, August 12, 2013. Howard Zauberman, Interim Chief Executive Officer, and John Vittoria, Interim VP Finance, will host a conference call to discuss the results as follows:
|Date:||Tuesday, August 13, 2013|
|Time:||8:30 a.m. ET|
|Conference dial-in:||(877) 303-1595 U.S.|
|(970) 315-0449 International|
An audio replay of the conference call will be available from 11:30 a.m. EDT on Tuesday, August 13, 2013, through 11:30 p.m. EDT on Monday, August 19, 2013, by dialing (855) 859-2056 from the U.S. or (404) 537-3406 from abroad. The audio webcast will also be available in the investor section of the Company's website, www.visionsciences.com .
About Vision-Sciences, Inc.Vision-Sciences, Inc. designs, develops, manufactures and markets products for endoscopy—the science of using an instrument, known as an endoscope, to provide minimally invasive access to areas not readily available to the human eye. Vision-Sciences' unique, flexible endoscopic products utilize a streamlined visualization system and proprietary sterile disposable sheaths, known as EndoSheath technology, to provide users quick, efficient endoscope turnover while ensuring enhanced patient safety through the use of sterile, single-use technology. Information about Vision-Sciences' products is available at www.visionsciences.com . Vision Sciences®, Slide-On®, EndoSheath®, EndoWipe® and The Vision System® are registered trademarks of Vision-Sciences, Inc.
CONTACT: John Vittoria Interim VP Finance Vision-Sciences, Inc. (845) 848-1085 firstname.lastname@example.org Lisa Wilson President In-Site Communications, Inc. (212) 452-2793 email@example.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts